Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 2
1967 1
1970 1
1971 2
1972 3
1973 3
1974 3
1975 4
1976 2
1977 1
1978 10
1979 3
1980 11
1981 7
1982 7
1983 7
1984 10
1985 14
1986 12
1987 8
1988 14
1989 7
1990 10
1991 5
1992 9
1993 9
1994 10
1995 11
1996 7
1997 9
1998 4
1999 6
2000 4
2001 5
2002 4
2003 1
2004 5
2005 4
2006 4
2008 4
2009 1
2010 2
2011 2
2012 2
2013 2
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Infliximab for induction and maintenance therapy for ulcerative colitis.
Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Rutgeerts P, et al. Among authors: rachmilewitz d. N Engl J Med. 2005 Dec 8;353(23):2462-76. doi: 10.1056/NEJMoa050516. N Engl J Med. 2005. PMID: 16339095 Free article. Clinical Trial.
Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P; SONIC Study Group. Colombel JF, et al. Among authors: rachmilewitz d. N Engl J Med. 2010 Apr 15;362(15):1383-95. doi: 10.1056/NEJMoa0904492. N Engl J Med. 2010. PMID: 20393175 Free article. Clinical Trial.
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group. Hanauer SB, et al. Among authors: rachmilewitz d. Lancet. 2002 May 4;359(9317):1541-9. doi: 10.1016/S0140-6736(02)08512-4. Lancet. 2002. PMID: 12047962 Clinical Trial.
Infliximab maintenance therapy for fistulizing Crohn's disease.
Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Sands BE, et al. Among authors: rachmilewitz d. N Engl J Med. 2004 Feb 26;350(9):876-85. doi: 10.1056/NEJMoa030815. N Engl J Med. 2004. PMID: 14985485 Free article. Clinical Trial.
Prostaglandins and diarrhea.
Rachmilewitz D. Rachmilewitz D. Dig Dis Sci. 1980 Dec;25(12):897-9. doi: 10.1007/BF01308037. Dig Dis Sci. 1980. PMID: 7449585 No abstract available.
On smoking, rats, and inflammatory bowel disease.
Rachmilewitz D. Rachmilewitz D. Gastroenterology. 1999 Oct;117(4):1008-11. doi: 10.1016/s0016-5085(99)70360-4. Gastroenterology. 1999. PMID: 10500084 Review. No abstract available.
Dermatomyositis associated with Crohn's disease.
Leibowitz G, Eliakim R, Amir G, Rachmilewitz D. Leibowitz G, et al. Among authors: rachmilewitz d. J Clin Gastroenterol. 1994 Jan;18(1):48-52. doi: 10.1097/00004836-199401000-00012. J Clin Gastroenterol. 1994. PMID: 8113586 Review.
[Probiotics--myth or benefit?].
Shibolet O, Eliakim R, Rachmilewitz D. Shibolet O, et al. Among authors: rachmilewitz d. Harefuah. 1999 Dec 15;137(12):620-3. Harefuah. 1999. PMID: 10959390 Review. Hebrew. No abstract available.
253 results